VANCOUVER, BC / ACCESSWIRE / January 11, 2018 / CVR Medical Corp. (TSX.V:CVM.V) (FRANKFURT: B3BN) (OTCQB: CRRVF) (“CVR Medical“) is pleased to announce the signing of an official Memorandum of Understanding with the Seoul Metropolitan Government
VANCOUVER, BC / ACCESSWIRE / January 9, 2018 / CVR Medical Corp. (TSX.V:CVM.V) (FRANKFURT: B3BN) (OTCQB: CRRVF) (“CVR Medical“) is pleased to announce IRB approval of clinical trials for its “Carotid Stenotic Scan (CSS)” device at
VANCOUVER, BC / ACCESSWIRE / January 2, 2018 / CVR Medical Corp. (TSX.V:CVM.V) (FRANKFURT: B3BN) (OTCQB: CRRVF) (“CVR Medical“) announces the signing of a manufacturing agreement with Canon Virginia, Inc., a manufacturing, engineering and technical operation
VANCOUVER, BC / ACCESSWIRE / November 21, 2017 / CVR Medical Corp. (TSX.V:CVM.V) (FRANKFURT: B3BN) (OTCQB: CRRVF) (“CVR Medical“) announces the full integration of the “Carotid Stenotic Scan (CSS)” wireless device into its late stage, ongoing
VANCOUVER, BC / ACCESSWIRE / November 15, 2017 / CVR Medical Corp. (TSX.V:CVM.V) (FRANKFURT: B3BN) (OTCQB: CRRVF) (“CVR Medical“) announces partnership with Rogan Molding Technologies. The Northbrook, IL company will be the exclusive manufacturer of the
VANCOUVER, BC / ACCESSWIRE / September 28, 2017 / CVR Medical Corp. (TSX.V:CVM.V) (FRANKFURT: B3BN) (OTCQB: CRRVF) (“CVR Medical“) announces the addition of Mr. Tim Knisley as Director of Finance and Controlling. Knisley will spearhead the
VANCOUVER, BC / ACCESSWIRE / September 20, 2017 / CVR Medical Corp. (TSX.V:CVM.V) (FRANKFURT: B3BN) (OTCQB: CRRVF) (“CVR Medical“) enters discussions with Key Opinion Leaders in the Chinese cardiovascular health industry, with whom the organization intends
VANCOUVER, BC / ACCESSWIRE / September 14, 2017 / CVR Medical Corp. (TSX.V:CVM.V) (FRANKFURT: B3BN) (OTCQB: CRRVF) (“CVR Medical“) announces the addition of Mr. Alan Langston to the company’s executive staff. Langston assumes the position of
VANCOUVER, BC / ACCESSWIRE / September 11, 2017 / CVR Medical Corp. (TSX.V:CVM.V) (FRANKFURT: B3BN) (OTCQB: CRRVF) (“CVR Medical“) is pleased to announce that an institutional research report has been released by RB Milestone Group, LLC
VANCOUVER, BC / ACCESSWIRE / September 8, 2017 / CVR Medical Corp. (TSX.V:CVM.V) (FRANKFURT: B3BN) (OTCQB: CRRVF) (“CVR Medical“) announces that Jeremy Poirier has provided his resignation as a director of CVR Medical to pursue his
VANCOUVER, BC / ACCESSWIRE / September 7, 2017 / CVR Medical Corp. (TSX.V:CVM.V) (FRANKFURT: B3BN) (OTCQB: CRRVF) (“CVR Medical“) advisory staff member Dr. Phillip J. Bendick, PhD, has released a summarized report on data from the
VANCOUVER, BC / ACCESSWIRE / August 22, 2017 / CVR Medical Corp. (TSX.V:CVM.V) (FRANKFURT: B3BN) (OTCQB: CRRVF) (“CVR Medical“) is pleased to announce the addition of Dr. Phillip J. Bendick, PhD, to the company’s advisory staff.
CVR Medical Corp. is a med-tech organization dedicated to the development and advancement of revolutionary technology at work within the healthcare sector. Specifically, The Carotid Stenotic Scan (CSS), a groundbreaking tool which will be used to assess Carotid Arterial health in a way which is unavailable to the patient, healthcare provider, and the payor within the current system. By leveraging intellectual property, market and industry know-how, and key strategic relationships, CVR Medical has entered into a trajectory which will revolutionize healthcare and dramatically improve clinical outcomes.